Hirsch IB, Draznin B, Buse JB, Raghinaru D, Spanbauer C, Umpierrez GE, Ullal J, Jones MS, Low Wang CC, Spanakis EK, Chao JH, Sibayan J, Kollman C, Zabala ZE, Moazzami B, Reynolds SL, Ferrara W, Fulghum K, Kass A, Armstrong C, Gilani F, Seggelke S, Churchill J, Monye JO, Choe MY, Scott W, Baran JD, Bais R, Khakpour D, Pasquel FJ, Davis GM, Vellanki P, Kershaw EE, Gligorijevic N, Goley A, Garg A, Alexander B, Matson BC, Diner J, Klein KR, Adair WB, Choksi P, Huang M, Vinh J, Singh LG, Beck RW. Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study. Diabetes Care. 2025 Jan 1;48(1):118-124. PubMed PMID: 39571106
Walter K, Choksi P, Papaleontiou M, Low Wang C, Gumber R, Park JM. Prescribing practices and barriers to use of sodium-glucose cotransporter 2 inhibitors and glucagon-like Peptide-1 receptor agonists in adult kidney transplant recipients: A survey of endocrinology and nephrology prescribers CPRR: CLINICAL PHARMACY RESEARCH REPORT; December 2024; https://doi.org/10.1002/jac5.2060
Lawrence, S. E., Chandran, M. M., Park, J. M., Sweiss, H., Jensen, T., Choksi, P., & Crowther, B. (2023). Sweet and simple as syrup: A review and guidance for use of novel antihyperglycemic agents for post-transplant diabetes mellitus and type 2 diabetes mellitus after kidney transplantation. Clinical transplantation, 37(3), e14922. https://doi.org/10.1111/ctr.14922
Choksi, P., Gay, B. L., Haymart, M. R., & Papaleontiou, M. (2023). Physician-Reported Barriers to Osteoporosis Screening: A Nationwide Survey. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(8), 606–611. https://doi.org/10.1016/j.eprac.2023.05.001